臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shih j y"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 626-650 / 1137 (共46頁)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-08-12T06:35:17Z	Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment	Chung K.-P.;Huang Y.-T.;Chang Y.-L.;Chong-Jen Yu;Yang C.-H.;Chang Y.-C.;Shih J.-Y.;Yang P.-C.; Chung K.-P.; Huang Y.-T.; Chang Y.-L.; CHONG-JEN YU; Yang C.-H.; Chang Y.-C.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2020-08-12T06:35:14Z	Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR	Shih J.-Y.; Yang P.-C.; Wei P.-F.; Chung K.-P.;Wu S.-G.;Wu J.-Y.;Yang J.-H.;Chong-Jen Yu;Wei P.-F.;Shih J.-Y.;Yang P.-C.; Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; CHONG-JEN YU
臺大學術典藏	2020-08-12T06:35:11Z	Effects of exercise training on exercise capacity in patients with non-small cell lung cancer receiving targeted therapy	Hwang C.-L.;Chong-Jen Yu;Shih J.-Y.;Yang P.-C.;Wu Y.-T.; Hwang C.-L.; CHONG-JEN YU; Shih J.-Y.; Yang P.-C.; Wu Y.-T.
臺大學術典藏	2020-08-12T06:35:08Z	Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis	Lee Y.-C.; CHONG-JEN YU; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; Yang P.-C.; Chang Y.-L.; Hu F.-C.; Wu S.-G.;Hu F.-C.;Chang Y.-L.;Lee Y.-C.;Chong-Jen Yu;Chang Y.-C.;Wu J.-Y.;Shih J.-Y.;Yang P.-C.; Wu S.-G.
臺大學術典藏	2020-08-12T06:35:07Z	Survival of lung adenocarcinoma patients with malignant pleural effusion	Wu S.-G.;Chong-Jen Yu;Tsai M.-F.;Liao W.-Y.;Yang C.-H.;Jan I.-S.;Yang P.-C.;Shih J.-Y.; Wu S.-G.; CHONG-JEN YU; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2020-08-12T06:34:34Z	Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer	CHONG-JEN YU; Chen C.-Y.;Chen Y.-Y.;Hsieh M.-S.;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Chong-Jen Yu; Chen C.-Y.; Chen Y.-Y.; Hsieh M.-S.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.
臺大學術典藏	2020-08-12T06:34:29Z	Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib	Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.H.; CHONG-JEN YU; Chen K.-Y.; Shih J.-Y.; Ho C.-C.; Liao W.-Y.; Yao Z.-H.; Yao Z.-H.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.H.;Chong-Jen Yu
臺大學術典藏	2020-08-12T06:34:19Z	Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients	Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; CHONG-JEN YU; Liao W.-Y.; Yao Z.-H.; Yao Z.-H.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.-H.;Chong-Jen Yu
臺大學術典藏	2020-08-12T06:34:19Z	A rare epidermal growth factor receptor H773L/V774M compound mutation in advanced non-small-cell lung cancer with poor response to epidermal growth factor receptor tyrosine kinase inhibitor	Yang C.-Y.; CHONG-JEN YU; Chen L.-C.;Shih J.-Y.;Chong-Jen Yu;Yang C.-Y.; Chen L.-C.; Shih J.-Y.
臺大學術典藏	2020-08-12T06:34:19Z	Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations	Lin Y.-T.;Chen J.-S.;Liao W.-Y.;Ho C.-C.;Hsu C.-L.;Yang C.-Y.;Chen K.-Y.;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU; Lin Y.-T.; Chen J.-S.; Liao W.-Y.
臺大學術典藏	2020-08-12T06:34:15Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Hsu C.-C.; Wu C.-T.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Yang C.-Y.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏	2020-08-12T06:34:13Z	Clinical factors associated with treatment toxicity of pemetrexed plus platinum in elderly patients with non-small cell lung cancer	Chen C.-Y.;Chen K.-Y.;Shih J.-Y.;Chong-Jen Yu; Chen C.-Y.; Chen K.-Y.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏	2020-08-12T06:34:11Z	Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma	Lu H.-H.;Lin S.-Y.;Weng R.R.;Juan Y.-H.;Chen Y.-W.;Hou H.-H.;Hung Z.-C.;Oswita G.A.;Huang Y.-J.;Guu S.-Y.;Khoo K.-H.;Shih J.-Y.;Chong-Jen Yu;Tsai H.-C.; Lu H.-H.; Lin S.-Y.; Weng R.R.; Juan Y.-H.; Chen Y.-W.; Hou H.-H.; Hung Z.-C.; Oswita G.A.; Huang Y.-J.; Guu S.-Y.; Khoo K.-H.; Shih J.-Y.; CHONG-JEN YU; Tsai H.-C.
臺大學術典藏	2020-08-12T06:34:10Z	Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer	Liu Y.-N.; CHONG-JEN YU; Shih J.-Y.; Lin Y.-T.;Tsai T.-H.;Wu S.-G.;Liu Y.-N.;Chong-Jen Yu;Shih J.-Y.; Lin Y.-T.; Tsai T.-H.; Wu S.-G.
臺大學術典藏	2020-08-12T02:50:46Z	Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis	Shih J.-Y.; CHAO-CHI HO; Yu K.-L.; Chen L.-Y.;Molina-Vila M.A.;Ruan S.-Y.;Su K.-Y.;Liao W.-Y.;Yu K.-L.;Chao-Chi Ho;Shih J.-Y.;Yu C.-J.;Yang J.C.H.;Rosell R.;Yang P.-C.; Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C.
臺大學術典藏	2020-08-12T02:50:43Z	Multiple Acquired Resistance Mutations of the ALK Tyrosine Kinase Domain?after Sequential Use of ALK Inhibitors	Wang H.-Y.; CHAO-CHI HO; Shih J.-Y.
臺大學術典藏	2020-08-12T02:50:43Z	Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer	Chen C.-Y.; Chen Y.-Y.; Hsieh M.-S.; CHAO-CHI HO; Chen K.-Y.; Shih J.-Y.; Yu C.-J.; Chen C.-Y.;Chen Y.-Y.;Hsieh M.-S.;Chao-Chi Ho;Chen K.-Y.;Shih J.-Y.;Yu C.-J.
臺大學術典藏	2020-08-12T02:50:43Z	Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib	Chao-Chi Ho;Liao W.-Y.;Lin C.-A.;Shih J.-Y.;Yu C.-J.;Chih-Hsin Yang J.; CHAO-CHI HO; Liao W.-Y.; Lin C.-A.; Shih J.-Y.; Yu C.-J.; Chih-Hsin Yang J.
臺大學術典藏	2020-08-12T02:50:43Z	Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit	Yu C.-J.; Shih J.-Y.; Chen Y.-F.; Lin J.-W.; CHAO-CHI HO; Yang C.-Y.; Chang C.-H.; Huang T.-M.; Chen C.-Y.; Chen K.-Y.; Chen Y.-F.;Lin J.-W.;Chao-Chi Ho;Yang C.-Y.;Chang C.-H.;Huang T.-M.;Chen C.-Y.;Chen K.-Y.;Shih J.-Y.;Yu C.-J.
臺大學術典藏	2020-08-12T02:50:42Z	Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib	Lin C.-C.; Yang J.C.H.; Yu C.-J.; Lin Z.-Z.; Chen J.-S.; Yao Z.-H.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Shih J.-Y.; Yao Z.-H.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.H.;Yu C.-J.
臺大學術典藏	2020-08-12T02:50:42Z	Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression	Chen C.-Y.;Chen Y.-Y.;Chen J.J.W.;Chen K.-Y.;Chao-Chi Ho;Shih J.-Y.;Chang Y.-L.;Yu C.-J.;Yang P.-C.; Chen C.-Y.; Chen Y.-Y.; Chen J.J.W.; Chen K.-Y.; CHAO-CHI HO; Shih J.-Y.; Chang Y.-L.; Yu C.-J.; Yang P.-C.
臺大學術典藏	2020-08-12T02:50:41Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Chao-Chi Ho;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; CHAO-CHI HO; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏	2020-08-12T02:50:40Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Lin C.-C.;Shih J.-Y.;Yu C.-J.;Chao-Chi Ho;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; CHAO-CHI HO; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.
臺大學術典藏	2020-08-12T02:50:40Z	Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery	Yang W.-C.; Xiao F.; Shih J.-Y.; CHAO-CHI HO; Chen Y.-F.; Tseng H.-M.; Chen K.-Y.; Liao W.-Y.; Yu C.-J.; Yang J.C.-H.; Kuo S.-H.; Cheng J.C.-H.; Yang P.-C.; Hsu F.-M.; Yang W.-C.;Xiao F.;Shih J.-Y.;Chao-Chi Ho;Chen Y.-F.;Tseng H.-M.;Chen K.-Y.;Liao W.-Y.;Yu C.-J.;Yang J.C.-H.;Kuo S.-H.;Cheng J.C.-H.;Yang P.-C.;Hsu F.-M.
臺大學術典藏	2020-08-12T02:50:39Z	Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum	Liao W.-Y.;Chao-Chi Ho;Tsai T.-H.;Chen K.-Y.;Shih J.-Y.;Yu C.-J.; Liao W.-Y.; CHAO-CHI HO; Tsai T.-H.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.

顯示項目 626-650 / 1137 (共46頁)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2826208
	造訪人次 : 31909051 線上人數 : 1280 教育部委託研究計畫計畫執行:國立臺灣大學圖書館